Jorgen Wittendorff
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jorgen Wittendorff
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
15
| Subsidiary | Biotechnology | 15 |
| Public Company | Miscellaneous Commercial Services | 11 | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jorgen Wittendorff via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Sonogene LLC | Director/Board Member | ||
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Founder | |
| ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Chicago Center for Clinical Research
 Chicago Center for Clinical Research Miscellaneous Commercial ServicesCommercial Services Part of CRA Holdings LLC, Chicago Center for Clinical Research is an American company that provides clinical research services. The company was founded by Michael H. Davidson. | Miscellaneous Commercial Services | Chief Executive Officer | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO General Counsel | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| The University of Sheffield | College/University | Doctorate Degree Undergraduate Degree | |
| University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Preventive Cardiology Institute, Inc. | Director/Board Member | ||
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
| BIOTALYS NV | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Inositec AG develops small molecules as alternatives to antibiotics. It also develops a non-antibiotic small molecule that neutralizes the toxins secreted by clostridium toxins. The company was founded by Mattias Ivarsson, Bastien Castagner and Jean-Christophe Leroux in December 2015 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
| SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member Investor Relations Contact | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chief Executive Officer | |
National Lipid Association
 National Lipid Association Miscellaneous Commercial ServicesCommercial Services The National Lipid Association aims to improve the practice of lipid management in clinical medicine. The non-profit company is based in Jacksonville, FL and has subsidiaries in the United States. The organization's mission is to enhance lipid management in clinical medicine, and its goals are consistent with this mission statement. | Miscellaneous Commercial Services | President | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Jocasta Neuroscience, Inc.
 Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Jocasta Neuroscience, Inc. provides biological products development services. The company is based in New Castle, DE. | Biotechnology | Director/Board Member | |
| Midwest Lipid Association | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 17 |
| Verenigd Koninkrijk | 7 |
| België | 7 |
| Denemarken | 6 |
| Frankrijk | 6 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 164 |
| Corporate Officer/Principal | 62 |
| Chairman | 58 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 45 |
Sterkste connecties
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| Bo Jesper Hansen | 34 |
| Catherine Moukheibir | 29 |
| Michael Davidson | 27 |
| Craig Tooman | 22 |
| David Solomon | 22 |
| Peter John Fellner | 21 |
| Peter Nordkild | 20 |
| Hilde Windels | 18 |
| Michel Lucien Pettigrew | 16 |
| Erik Schropp | 15 |
| Mark Rothera | 14 |
| Per Gunnar Falk | 12 |
| Antonius Berkien | 11 |
| Diane Carman | 9 |
- Beurs
- Insiders
- Jorgen Wittendorff
- Bedrijfsconnecties
